https://www.selleckchem.com/pr....oducts/pf-04418948.h
6%) patients, respectively. All graft prostheses were patent at last follow-up. Using bifurcated Omniflow II vascular prostheses in patients with or at a high risk of vascular graft infection is advisable, and is associated with acceptable reinfection and patency rates. Using bifurcated Omniflow II vascular prostheses in patients with or at a high risk of vascular graft infection is advisable, and is associated with acceptable reinfection and patency rates. Mitral valved stents tend to migrate or to develop paravalvular leakage d
Like
Comment
Share
